EuroAPI Header EuroAPI Header

X

Digital content for NiKang Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
NiKang Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
NiKang Therapeutics, Inc. 200 Power Mill Road BLDG E400 Wilmington, DE 19803
Telephone
Telephone
(302) 644-5450
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240415891824/en

BUSINESSWIRE
15 Apr 2024

https://www.businesswire.com/news/home/20240104711860/en

BUSINESSWIRE
04 Jan 2024

https://www.businesswire.com/news/home/20231208330578/en

BUSINESSWIRE
08 Dec 2023

http://www.pharmabiz.com/NewsDetails.aspx?aid=155862&sid=2

PHARMABIZ
20 Jan 2023

https://www.businesswire.com/news/home/20230118005191/en

BUSINESSWIRE
18 Jan 2023

https://www.businesswire.com/news/home/20220503005332/en

BUSINESSWIRE
03 May 2022

https://www.businesswire.com/news/home/20220408005045/en

BUSINESSWIRE
08 Apr 2022

https://www.businesswire.com/news/home/20220105005121/en

BUSINESSWIRE
05 Jan 2022

https://www.businesswire.com/news/home/20211115005201/en

BUSINESSWIRE
15 Nov 2021

https://www.businesswire.com/news/home/20211115005201/en/NiKang-Therapeutics-Announces-First-Patient-Dosed-in-A-Phase-12-Study-Evaluating-NKT2152-a-Small-Molecule-that-Inhibits-Hypoxia-Inducible-Factor-2%CE%B1-HIF2%CE%B1-for-the-Treatment-of-Advanced-Clear-Cell-Renal-Cell-Carcinoma

BUSINESSWIRE
15 Nov 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY